High Pasta vs. Low Pasta Diet in the Treatment of Obesity
- Conditions
- Diet Therapy
- Interventions
- Behavioral: Low PastaBehavioral: High Pasta
- Registration Number
- NCT03341650
- Lead Sponsor
- University of Parma
- Brief Summary
To the best of our knowledge, the effect of pasta consumption within a hypocaloric Mediterranean diet has only been scarcely explored yet. Therefore, a two-parallel group dietary intervention was carried out to investigate if pasta consumption could affect the BMI change in obese patients. The primary outcome was the loss of at leat 8% of the initial body weight in the first 6 months. Anthropometric and body composition (from bioelectrical impedance analysis - BIA-) measures were collected every month for the first 6 months and after 1 year. In addition, dietary information was collected at baseline and after 3, 6 and 12 months through a 7-day carbohydrate food record and a 24-h food recall. Blood samples were collected at baseline and at 6 and 12 months to assess: glucose, insulin, Homeostatic model assessment for insulin resistant (HOMA-IR) index, total cholesterol, low-density lipoprotein, high-density lipoprotein, and uric acid. Furthermore, the perceived quality of life was investigated through the 36-items short form health survey (SF36) questionnaire.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44
- BMI between 30-45 kg/m2
- healthy subjects
- regular meal consumption
- no celiac disease
- no menopause woman
- with a BMI <30 or >45 kg/m2
- having diabetes, hepatic or kidney diseases
- having an eating disorder
- having celiac disease
- menopause woman
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low Pasta Low Pasta Habitual pasta consumption equal or lower than 3 times/week. High Pasta High Pasta Habitual pasta consumption equal or higher than 5 times/week.
- Primary Outcome Measures
Name Time Method Change from baseline Body weight at 6 months baseline, 6 months Measured in kg according to the standard procedure
- Secondary Outcome Measures
Name Time Method Waist circumference baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months Measured in cm according to the standard procedure
Glucose baseline, 6 months, 12 months mg/dL in fasting condition
Change from baseline Body weight at 3 months baseline, 3 months Measured in kg according to the standard procedure
Change from baseline Body weight at 12 months baseline, 12 months Measured in kg according to the standard procedure
Fat Mass baseline, 3 months, 6 months, 12 months Estimated by bioelectrical impedance analysis in kg and in %
Basal Metabolic Rate baseline, 3 months, 6 months, 12 months Estimated by bioelectrical impedance analysis in kcal/day
HOMA-IR index baseline, 6 months, 12 months calculated from glucose and insulin in fasting condition
HDL cholesterol baseline, 6 months, 12 months mg/dL in fasting condition
Energy intake baseline, 3 months, 6 months, 12 months assessed by a 24-h dietary recall as kcal/day
Nutrient intakes baseline, 3 months, 6 months, 12 months assessed by a 24-h dietary recall as g/day
Carbohydrate-based food intakes baseline, 3 months, 6 months, 12 months assessed by a 7-day food diary as times/week
Triglycerides baseline, 6 months, 12 months mg/dL in fasting condition
Insulin baseline, 6 months, 12 months microU/mL in fasting condition
Total cholesterol baseline, 6 months, 12 months mg/dL in fasting condition
Perceived Quality of Life baseline, 3 months, 6 months, 12 months assessed by the SF36 questionnaire
BMI baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months Calculated as body weight in kilograms divided by the square of the height in meters
Free Fat Mass baseline, 3 months, 6 months, 12 months Estimated by bioelectrical impedance analysis in kg and in %
LDL cholesterol baseline, 6 months, 12 months mg/dL in fasting condition
Uric Acid baseline, 6 months, 12 months mg/dL in fasting condition
Trial Locations
- Locations (1)
Department of Food and Drug, University of Parma
🇮🇹Parma, Italy